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Objective(s): Various microRNAs (miRNAs) are expressed during development of mammalian cells, 
when they aid in modulating gene expression by mediating mRNA transcript cleavage and/or 
regulation of translation rate. miR-191 and miR-451 have been shown to be critical regulators of 
hematopoiesis and have important roles in the induction of erythroid fate decision. So, the aim of this 
study is investigation of the miR-191 and miR-451 roles in the controlling mouse embryonic stem cell 
(mESC) differentiation toward the erythroid lineage.
Materials and Methods: mESCs were infected with either pCDH-miR-Off-191 viruses in pCDH-miR-Off-191 
group or simultaneously with pCDH-miR-Off-191 and pCDH-miR-451 lentiviruses in simultaneous  group. 
Then, the expression profiles of erythroid specific transcription factors and globin genes were analyzed 
using QRT-PCR on day 14 and 21 of differentiation. Flow cytometry analysis was used to evaluate of TER119 
and CD235a erythroid specific surface markers. 
Results: Gata-1, Klf-1, Epor and globin chains were found to be expressed in pCDH-miR-Off-191 and 
in simultaneous groups. The majority of globin chains showed changes in their expression levels with 
progression of differentiation from day 14 to day 21. Flow cytometry results showed that miR-451 up- 
regulation and miR-191 down-regulation is associated with the expression of TER119 and CD235a. 
Of these two groups analyzed, simultaneous group was most significantly potent in stimulation of 
erythroid fate decision of mESCs. 
Conclusion: Together, present data demonstrate that down-regulation of miR-191 alone can enhance 
the differentiation of mESCs. However, the simultaneous effect of miR-451up-regulation and miR-191 
down-regulation is much stronger and can have more practical use in artificial blood production.
Article history:
Received: Nov 26, 2017






Mouse embryonic stem cell
►Please cite this article as:  
Shokri G, Kouhkan F, Nojehdehi Sh, Soleimani M, Pourfathollah AA, Nikougoftar Zarif  M, Tamaddon M, Obeidi N. Simultaneous regulation of miR-451 
and miR-191 led to erythroid fate decision of mouse embryonic stem cell. Iran J Basic Med Sci 2019; 22:432-438. doi: 10.22038/ijbms.2019.27919.6795
Introduction
Survival without blood is not possible (1). Low blood 
supplies especially in developing countries, lower 
number of donors owing to the aging of population and 
consequently increased demand for blood products, 
short storage period, and urgent needs for blood 
supplies during wartime and natural disasters are 
important reasons that caused the scientists started to 
think about a proper replacement such as an artificial 
blood (2, 3). Some kind of blood substitutes developed 
over time, including red blood cells (RBCs) isolated 
from donated blood, perfluorochemicals (PFCs), Hb-
based RBC substitutes, but the real RBCs are RBCs 
differentiated from stem cells (4, 5). RBC-derived stem 
cells used as an ideal product for injection to patients 
needing blood transfusion as well as patients with rare 
blood groups or autoantibodies (6). For this reason, stem 
cells could be derived from various sources such as bone 
morrow, cord blood, embryonic stem cells, and induced 
pluripotent stem cells (iPSCs) (7-9). However, there 
are most important problems at clinical applications 
including mass production and high production costs 
for the use of various cytokines and growth factors. It 
would be expected to overcome these obstacles through 
genetic manipulations of the molecular mechanism 
in order to direct the fate decision of the stem cells to 
erythroid lineage and make an unlimited source with 
maximum similarity and minimum costs to replace RBCs 
derived from donated blood. Therefore, the exact study 
of the molecular processes governing the differentiation 
of stem cells into blood cells is very much considered. 
In this field, a large body of recent studies has 
suggested that single-stranded RNA molecules of 21–
23 nucleotides, termed as microRNAs (miRNAs), play 
critical roles in differentiation processes of stem cells 
into RBC lineage (10, 11). Specific miRNAs are key 
regulators of each stage of erythropoiesis, including 
erythroid lineage determination, erythroid progenitor 
proliferation, terminal erythroid differentiation, and 
enucleation (12, 13). Jin and coworker demonstrated 
that expression levels of miR-142-3p, miR-142-5p, miR-
146a and miR-451 were dynamically changed during 
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differentiation of hESCs to CD34+ hematopoietic cells, 
and in subsequent differentiation of the CD34+ cells 
into the erythroid lineage (14). In the other study the 
expression profile of 295 miRNAs before and after their 
induction to erythroid differentiation was analyzed 
using microarray. Among them, miR-451 was most 
significantly up-regulated during erythroid maturation 
(15). Also, Kouhkan et al. indicated that expression 
modulation of miR-451 and miR-150 could be an 
efficient alternative to stimulatory cytokines for CD133+ 
differentiation into erythroid lineage (16). Regulated 
expression of several miRNAs is also important in 
terminal erythroid differentiation for erythroblast 
chromatin condensation and enucleation (17, 18). 
For example, Riok3 and Mxi1, which are required for 
chromatin condensation and enucleation, are direct 
miR-191 targets (19). So, ectopic overexpression of 
miR-191 in mouse fetal liver erythroid progenitors 
blocked erythroid enucleation but had minor effects on 
proliferation or erythroid differentiation. 
Since, the major problem of patients with 
hemoglobinopathies, such as sickle cell anemia and 
thalassemia is failure in the production of adult globin 
(HbA), reactivation of the α- and β-globin chains could 
somewhat improve the lethality of α- and β-thalassemia 
(20, 21).
So, taking into account the importance of miRNAs 
in differentiation, the aim of this study is to investigate 
whether synchronous regulation of miR-451 and miR-
191 could emerged as a replacement to the stimulatory 




Murine ESC (mESC) [E14Tg2A] lines were cultured 
feeder-free on 0.1% gelatin-coated (Sigma, USA) plates 
in ESC medium (Dulbecco’s modified Eagle’s medium, 
15% heat-inactivated embryonic stem-standard fetal 
bovine serum [Gibco, USA], 1 mM nonessential amino 
acids [Gibco, USA], 2 mM L-glutamine [Euroclone, 
Italy], 55 nM -mercaptoethanol, 1% [vol/vol] penicillin/ 
streptomycin [Euroclone, Italy], and mouse leukemia 
inhibitory factor [mLIF; 103 U/ml; Sigma, USA]). 
Human embryonic kidney (HEK) 293 cell lines were 
obtained from Pasteur Institute of Iran and cultured 
in high-glucose Dulbecco’s modified Eagle medium 
(DMEM, Gibco, USA) containing 10% fetal bovine serum 
(FBS, Gibco, USA) and 1% nonessential amino acids 
(Invitrogen, USA), penicillin (100 U/ml, Gibco, USA), 
streptomycin (0.1 mg/ml, Gibco,  USA), and L-glutamine 
(2 mM, Gibco, USA). Cells were cultured under standard 
condition in 95% humidity and 5% CO2 at 37 °C.
Recombinant lentivirus generation and infection
For gain of function study, pCDH-miR-451 recombinant 
lentivector construct was cloned as described previously 
(22). For loss of function study, shRNA structure of 
mutant form of miR-191 was cloned into the pCDH-CMV-
MCS-EF1-copGFP plasmid to create pCDH-miR-Off-191. 
Empty vector without any cloned sequence (pCDH-Ctrl) 
was employed as controls in all experiments. 
For lentivirus production, HEK-293T cells were 
calcium phosphate co-transfected with pCDH-miR-451/ 
pCDH-miR-Off-191 or pCDH-Ctrl, pPAX2 plasmid 
(packaging plasmid) and pMD2 plasmid (containing 
vsv gene). The supernatants were harvested every 12 
hours for 3 days after transfection and concentrated by 
ultracentrifuge at 47,000×g for 2 hr at 4 °C. 
To induce erythroid differentiation, mESCs were 
cultured in leukemia inhibitory factor (LIF)-deficient 
medium and transduced with pCDH-miR-Off-191 and 
pCDH-miR-451 lentivirus. 
Then, the effect of miR-451 up-regulation and miR-
191 down-regulation on erythroid differentiation was 
measured over a period of 14 days and 21 days. 
RNA extraction, RT-PCR and quantitative RT–PCR 
assays 
Total RNAs were extracted from all group of study 
using TRizol reagent according to the manufacturer’s 
instructions (Invitrogen, USA). cDNA was synthesized 
with 200 ng of total RNA using M-MuLV reverse 
transcriptase (Promega, USA) and random hexamers 
(for mRNAs) or stem-loop RT specific primers (for miR-
451, miR-191 and SNORD234). 
Quantitative real-time PCR was performed using the 
ABI 157 PRISM 7500 real-time PCR system (Applied 
Biosystems). Normalization was performed with 
β2M and SNORD234 for mRNAs and miRNAs genes, 
respectively. Finally data analyses were performed 
using 2−∆∆CT method. Primer sequences are given in the 
supplemental Table 1.
Flow cytometry
For erythroid-specific surface markers detection 
(Ly76: TER119 and glycophorin A receptor: CD235a) 
mESC samples from all groups were collected at days 
14 and 21, washed with PBS and immunostained with 
purified PE -conjugated antibody against CD235a 
(1:200), PE-conjugated antibody against TER119 
(1:200, BD Pharmingen, USA) and isotype-matched 
control antibodies (DAKO Denmark) for 60 min at 4 °C 
in dark. Harvested cells then examined on FACScan flow 
cytometry PartecPAS III (Partec, Germany).
Statistical analysis
All experiments were performed at least three times, 
presented as means±standard deviation (SD) and 
analyzed by student’s t test. Values with P<0.05 were 
considered statistically significant.
Treatment   Day 14 Day 21 
The percentage of the cells expressing TER119  
 
pCDH-miR-Off-191 group   
Coordinate group                                                                32.25±3.34 75.34±3.7 
pCDH-Ctrl 3±1.21 3.90±1.41 
Control 3.87±0.54 4.07±0.91 
The percentage of the cells expressing CD235a 
 
pCDH-miR-Off-191 group  10.47±2.78 18.7±3.97 
Coordinate group 25.57±2.21 65.86±2.64 
pCDH-Ctrl 3.84±1.64 6.5±2.43 
Control 2.05±0.52 5.32±5.33 
 
Table 1. The proportion of the cells expressing TER119 and CD235a
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Results
Simultaneous regulation of miR-451 and miR-191 in 
mESCs promoted erythroid differentiation
In the previous study, we indicated that pCDH-
miR-451 could induce erythtroid fate determination in 
mESCs (23). According to importance of miR-191 down- 
regulation in erythroblast enucleation as erythroid 
specific miRNAs, in the present study, the effects of 
simultaneous regulation of these two important miRNAs 
and the effect of miR-191 down-regulation alone were 
investigated in differentiation induction.  
So, in order to drive mESCs to enter erythroid 
commitment, cells were transduced with pCDH-miR-451 
and/or pCDH-miR-Off-191 expressing copGFP and 
used to form EBs in suspension culture. Transduction 
efficiency was checked through monitoring of CopGFP 
expression by fluorescent microscope. Approximately 
80% of the cells in transduced groups with green 
fluorescent were detected 48 hr after infection. No 
fluorescent-positive cell was detected in control group 
that did not receive any treatment, as shown in Figure 2: 
Expression analysis of erythroid specific transcription 
factors in transduced mESC on the 14 and 21 day in 
transduced mESCs. In the absence of cytokines, down-
regulation of miR-191 could induce transcription of 
lineage-specific factors and promote erythroid fate 
decision. Results presented as fold change compared 
to the control cells. Data are mean ± SD from three 
independent experiments. Error bars represent SD. 
*P<0.05 group (transduced simultaneously with 
pCDH-miR-451 and pCDH-miR-Off-191) and pCDH-
miR-Off-191 group and miR-451 was up-regulated in 
the simultaneous group as comparing to the control 
groups (no vector group and pCDH-Ctrl group) after 
transduction. 
To further confirmation that Riok3 and Mxi1 are direct 
targets of miR-191 during terminal differentiation of 
erythroids, we measured Riok3 and Mxi1 transcripts on 
day 14 and 21 differentiation. Our results indicated that 
down-regulation of miR-191 increased the expression 
 
  
Figure 1. Expression levels of miRNAs in transduced groups on day 14 and 21. A) Expression level of miR-191 in pCDH-miR-Off-191 group. B) 
Expression level of miR-191 and miR-451 in simultaneous group. Each test was performed triplicate and results were reported as mean±SD of 3 
expriments. Error bars indicate SD. *P<0.05
 
  
Figure 2. Expression analysis of erythroid specific transcription factors in transduced mESC on the 14 and 21 day in transduced mESCs. In the 
absence of cytokines, down-regulation of miR-191 could induce transcription of lineage-specific factors and promote erythroid fate decision. 
Results presented as fold change compared to the control cells. Data are mean±SD from three independent experiments. Error bars represent SD. 
*P<0.05
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of Riok3 and Mxi1 (Figure 2A). Additionally, since, miR-
451 through direct targeting of 14-3-3 ζ and GATA2 
involve in erythroid differentiation, the expression level 
of these proteins were also examined (Figure 2B). Over-
expression of miR-451 specifically reduced 14-3-3ζ 
and GATA2 mRNA expressions in simultaneous group 
demonstrating that putative targets transcript levels 
correlates inversely with miR-451 levels.
Next, to verify the direction of the differentiation 
path, we investigated the effects of miR-451 and miR-
191 modulation on the expression pattern of several 
erythroid-specific marker genes by quantitative RT-PCR. 
In the simultaneous group, gene expression analysis 
showed elevated expression levels of Epor and Klf-1 
mRNAs on day 14 and their expressions remained high 
until the end of experiment. GATA1 mRNA level was up-
regulated on day 14 but decreased to 0.36 fold on day 21 
(Figure 3A-B). 
In the case of pCDH-miR-Off-191, highest expression 
level of Epor and Klf-1 were observed on day 21 (with an 
increase of 6.27 and 38.31 times, respectively, compared 
to the control group) Gata-1 expression only detected 
14 days after differentiation (Figure 3C-D). 
The expression profile of hemoglobin chains were 
also examined in tansduced groups (Figure 4). mRNA 
of ε, γ and α genes were significantly overexpressed in 
 
  
Figure 3. Expression analysis of hemoglobin chains in transduced mESC on the 14 and 21 day.  In pCDH-miR-Off-191, down-regulation of miR-191 
leads to significant rise of γ and α transcripts on day 14 and 21. Expression of β chain only was observed on day 21. Coordinate modulation of miR-
191 and miR-451 had major effect on the transcription of erythroid specific markers and leading to a significant rise of α, γ and β transcripts on 
day and 14 and 21. Data are mean ± SD from three independent experiments. Error bars represent SD. *P<0.05
 
  
Figure 4. Appearance of TER119 and CD235a in mESCs on day 14 and 21 in pCDH-miR-Off-191 group. Down-regulation of miR-191 had positive 
correlation with expression of erythroid surface specific marker. A) The percentage of the cells expressing TER119 on day 14 in pCDH-miR-Off-191 
group (Upper) and in pCDH-Ctrl group (Lower). B) The percentage of the cells expressing TER119 on day 21 in pCDH-miR-Off-191 group (Upper) 
and in pCDH-Ctrl group (Lower). C) The percentage of the cells expressing CD235a on day 14 in pCDH-miR-Off-191 group (Upper) and in pCDH-Ctrl 
group (Lower). D) The percentage of the cells expressing CD235a on day 21 in pCDH-miR-Off-191 group (Upper) and in pCDH-Ctrl group (Lower)
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simultaneous group (6.02-fold, 22.31-fold and 17.72-
fold respectively), and in pCDH-miR-Off-191 group 
(3.13-fold, 4.02-fold and 10.55-fold) compared with 
pCDH-Ctrl control group on day 14.  
At day 21, expression of ε, α and β-globin genes reached 
its highest level in simultaneous group (by 7.3- fold, 
31.6- fold and 45.2-fold, respectively) compared with the 
untreated control group (P<0.05). Knockdown of miR-
191 had positive effects on the mRNA expression of ε, α 
and β-globin genes. There were no significant changes 
in the expression profile of hemoglobin chain genes in 
control group (no vector) and pCDH-Ctrl group during 
the course of differentiation. Collectively, these results 
confirmed that simultaneous regulation of miR-191 and 
miR-451 stimulates the expression of genes involved in 
the erythroid differentiation pathway more potently.
TER-119 and CD235a were expressed in both pCDH-
miR-Off-191 group and simultaneous group
Expression of TER119 and CD235a consider as key 
indicators of erythropoiesis. As shown in Table 1, flow 
cytometry results demonstrated that in the pCDH-miR-
Off-191 group, knockdown of miR-191increased the 
number of the cells expressing TER119 and CD235a 
(15 ± 3.34% and 10.47± 2.78%, respectively, compared 
with 3± 1.21% and 2.98 ± 1.52% of the pCDH-Ctrl) on 
day 14. On day 21, results indicated that the positive cell 
population for TER119 and CD235a were 21± 2.61% 
and 18.7± 3.97% in pCDH-miR-Off-191 treated mESCs 
and 3.90 ± 1.41% and 3.13 ± 1.45% in pCDH-Ctrl group, 
respectively (Figure 3).
The results of the flow cytometry show that 
simultaneous regulation of the miR-451 and miR-
 
  
Figure 5. Appearance of TER119 and CD235a in mESCs on day 14 and 21 in pCDH-miR-Off-191 group. Down-regulation of miR-191 had positive 
correlation with expression of erythroid surface specific marker. A) The percentage of the cells expressing TER119 on day 14 in pCDH-miR-Off-191 
group (Upper) and in pCDH-Ctrl group (Lower). B) The percentage of the cells expressing TER119 on day 21 in pCDH-miR-Off-191 group (Upper) 
and in pCDH-Ctrl group (Lower). C) The percentage of the cells expressing CD235a on day 14 in pCDH-miR-Off-191 group (Upper) and in pCDH-Ctrl 




Figure 6. Expression of TER119 and CD235a on the surface of transduced  mESCs after 14 and 21 day in simultaneous group. Simultaneous modulation 
of miR-451 and miR-191 leads to the emergence of TER119 and CD235a. A) The population of the cells positive for TER119 on day 14 in simultaneous 
group (Upper) and in pCDH-Ctrl group (Lower). B) The population of the cells positive for TER119 on day 21 in simultaneous group group (Upper) 
and in pCDH-Ctrl group (Lower). C) The population of the cells positive for CD235a on day 14 in simultaneous group (Upper) and in pCDH-Ctrl group 
(Lower). D) The population of the cells positive for CD235a on day 21 in simultaneous group (Upper) and in pCDH-Ctrl group (Lower)
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191 significantly increased the percentage of the cells 
expressing TER119 and CD235a to 32.25 ± 3.34%  and 
25.57 ± 2.21% at day 14 and 75.34 ± 3.71% and 65.86 ± 
2.64% at day 21 (Figure 4). 
Discussion
It is clear that much attention has been devoted to the 
role of miRNAs in erythroid lineage commitment over the 
past few years (24-26). Previously, it has been thought 
that the production of erythroid cells are regulated only 
by cytokines, including erythropoietin, IL-3, IL-6, stem 
cell factor, glucocorticoids and TPO that activate the JAK/
STAT, RAS/ MAPK and PI3K/AKT pathways, all of which 
finally regulate transcription factors, such as GATA1, 
TAL1/SCL, STAT5 and KLF1, to eventually modulate 
the expression of genes required for fate decision and 
differentiation (27-30). The identification of miRNAs 
that are required for erythroid cell lineage commitment 
discovers another layer of ‘decision-making’ process.
In the previous study, we demonstrated that miR-
451 plays an important role in promoting erythroid 
maturation and accelerated the rate of erythroid 
differentiation of the mESCs, an action mediated in part 
by repression of GATA2 (23). Here, we indicated that 
another part of the miR-451’s activity is applied through 
protects against erythroid oxidant stress by repressing 
14-3-3ζ .14-3-3 ζ is a phospho-serine/threonine-
binding protein that inhibits nuclear accumulation 
of transcription factor FoxO3, a positive regulator of 
erythroid anti-oxidant genes (31, 32).
On the other hand, terminal erythroid differentiation 
is a synchronized process that involves four to five cell 
divisions, expression of many erythroid-important 
genes, chromatin condensation, and enucleation  (33). 
miR-191 was identified as one of essential down- 
regulated miRNAs for erythroid chromatin condensation 
and enucleation by allowing up-regulation of Riok3 and 
Mxi1(34-36). In the present study, we also confirmed 
that miR-191 through direct targeting of Riok3 and 
Mxi1induce erythroid differentiation in mESCs.
So, according to important roles of miR-451 and miR-
191,  mESCs were transduced with pCDH-miR-Off-191 
and/or pCDH-miR-451 and evaluated for emergence of 
erythroid-specific markers.
Erythroid specific transcription factors evaluation 
indicated that expression of all three GATA1, FOG-
1, and EKLF factors were observed on 14st day of 
differentiation. FOG-1 and EKLF had a sharp increase 
on day 21. But, GATA1 expression fell down on day 21 
especially in the simultaneous group. In fact, GATA1 is 
essential for normal erythropoiesis as GATA1-deficient 
embryonic stem cells are able to contribute to all 
different tissues in chimeric mice, with the exception 
of the mature red blood cells. However, at late stages of 
erythroid differentiation, GATA1 degraded by caspases 
that leads to a reduction of GATA1 levels and allowing 
terminal differentiation (37-39).
Further study on expression profile of hemoglobin 
chains using qRT-PCR indicated that increase 
accumulation were detected for ε, γ and ζ globin chains 
transcripts on day 14 and for α and ε globin chains 
transcripts on day 21 in the pCDH-miR-Off-191 group. β 
globin was found in the simultaneous group, at a lower 
level on day 14 and more on day 21 and in the pCDH-miR-
Off-191 group, only on day 21. β globin chain expression 
on the 21st day in the simultaneous group is about twice 
the pCDH-miR-Off-191 group. These results showed 
that miR-451 has the dominant effect on the expression 
of the β gene and producing of adult hemoglobin and 
further confirmed some previous studies indicating that 
miR-451 has strong positive association with the late 
stage of erythropoiesis.
Next, the correlation between miR-451 up-regulation 
and miR-191 down-regulation with appearance of 
erythroid specific surface marker as another indexes 
of erythroid differentiation were investigated. TER-
119 is an erythroid-specific cell surface marker that 
expressed at all stages of differentiation from early 
proerythroblasts to mature erythrocytes. TER-119 
marker was demonstrated to be expressed on day 14 
and gradually increased on the 21st day in pCDH-miR-
Off-191 group. In this group, CD235a expression was 
about 10% on day 14, which increased by about 18% on 
day 21. In the simultaneous group, expression changes 
were more dramatic: TER-119 marker was expressed 
about 32% on day 14 and rose to its highest level on the 
21st day. CD235a expression increased on day 14 and 
gradually reached to the peak level on day 21.
Conclusion
Declined levels of miR-191, to some extent, can 
enhance differentiation of mESCs alone, where this 
miRNA exerts its effects through post-transcriptional 
regulation of multiple mRNAs, including translation 
attenuation of Riok3 and Mxi1. However, the 
simultaneous modulation of miR-451 and miR-191 is far 
more influential in erythroid induction. These findings 
will aid in our understanding of miRNA function 
in embryonic stem cells and facilitate our ability to 
enhance the differentiation of erythroid cell lineages 
and production of artificial RBCs without the presence 
of any stimulatory cytokines. 
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